VRise Therapeutics, Inc. Press Releases

• Published on November 20, 2024 - 09:55 GMT

  

  VRise Therapeutics Inc. Announces Acceptance of Late Breaking Abstract for San Antonio Breast Cancer Symposium®

  CAMBRIDGE, MA, UNITED STATES, November 20, 2024 /⁨EINPresswire.com⁩/ -- VRise Therapeutics Inc. will be presenting groundbreaking findings at the upcoming San Antonio Breast Cancer Symposium®, set to take place on December 10-13 in San Antonio, TX 78205 …

  Distribution channels: Banking, Finance & Investment Industry, Companies ...
• Published on October 15, 2024 - 13:46 GMT

  

  VRise Therapeutics Inc. Announces Acceptance of Late Breaking Abstract at 36th EORTC-NCI-AACR for USP1 Inhibitor VRTX531

  Late Breaking Presentation entitled "VRTX531, a Best-in-Class USP1 Inhibitor for Homologous Deficient Tumors" CAMBRIDGE, MA, UNITED STATES, October 15, 2024 /⁨EINPresswire.com⁩/ -- VRise Therapeutics Inc. is excited to announce that its abstract …

  Distribution channels: Banking, Finance & Investment Industry, Companies ...
• Published on October 3, 2024 - 13:55 GMT

  

  VRise Therapeutics Inc. Appoints Dr. Francesco Bertoni, an Expert Hemato-Oncologist

  CAMBRIDGE, MA, UNITED STATES, October 3, 2024 /⁨EINPresswire.com⁩/ -- VRise Therapeutics, Inc., a precision oncology company, announced today the appointment of renowned expert in translational oncology, Dr. Francesco Bertoni, as an advisor. Dr. Bertoni …

  Distribution channels: Business & Economy, Companies ...
• Published on June 30, 2023 - 12:36 GMT

  VRise Expands Scientific Advisory Board with the Addition of Leading Clinical and Translational Cancer Expert

  VRise Therapeutics Inc. builds out advisory team with key appointment Dr. Colin Weekes of Harvard Medical School and Massachusetts General Hospital. CAMBRIDGE, MASSACHUSETTS, USA, June 30, 2023 /⁨EINPresswire.com⁩/ -- VRise Therapeutics Inc., a precision …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on August 1, 2022 - 11:00 GMT

  

  Distinguished Oncologist Dr. Junji Furuse To Join VRise Therapeutics Scientific Advisory Board

  Dr. Junji Furuse is President of Kanagawa Cancer Center, A Comprehensive Cancer Research Center and Hospital in Yokohama, Japan CAMBRIDGE, MASSACHUSETTS, USA, August 1, 2022 /⁨EINPresswire.com⁩/ -- VRise Therapeutics Inc., a precision oncology company, …

  Distribution channels: Business & Economy, Companies ...
• Published on July 26, 2022 - 13:12 GMT

  

  VRise Therapeutics Inc. Announces Expansion of its Scientific Advisory Board

  New advisors include leading experts in Molecular & Cancer biology, CADD & AI and Drug Delivery CAMBRIDGE, MA, U.S.A., July 26, 2022 /⁨EINPresswire.com⁩/ -- VRise Therapeutics Inc., a precision oncology company, aspiring to bring breakthrough …

  Distribution channels: Banking, Finance & Investment Industry, Companies ...
• Published on July 11, 2022 - 11:00 GMT

  

  VRise Therapeutics Announces Eminent Oncologist Dr. Anthony W. Tolcher Joining its Scientific Advisory Board

  Dr. Anthony W. Tolcher is CEO & Founder and Director of Clinical Research at NEXT Oncology, San Antonio, Texas, U.S.A. CAMBRIDGE, MASSACHUSETTS, UNITED STATES, July 11, 2022 /⁨EINPresswire.com⁩/ -- VRise Therapeutics, Inc., a precision oncology …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on July 4, 2022 - 10:00 GMT

  

  VRise Therapeutics Announces Joining of Dr. Darren Tyson, Vanderbilt University, to its Scientific Advisory Board

  Dr. Darren Tyson is Research Associate Professor of Biochemistry at Vanderbilt University School of Medicine CAMBRIDGE, MASSACHUSETTS, UNITED STATES, July 4, 2022 /⁨EINPresswire.com⁩/ -- a precision oncology company, aspiring to bring breakthrough novel …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on March 8, 2022 - 23:47 GMT

  

  VRise Therapeutics, Inc. announces scientific presentations at the upcoming AACR Annual Meeting, 2022

  CAMBRIDGE, MASSACHUSETTS, UNITED STATES, March 8, 2022 /⁨EINPresswire.com⁩/ -- VRise Therapeutics, Inc., a precision oncology company, today announced that it is presenting at the upcoming AACR Annual Meeting 2022, April 08-13 at Ernest N. Memorial …

  Distribution channels: Business & Economy, Companies ...